EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII

Suleyman Akocak iD, Nebih Lolak iD, Andrea Ammara, Gökçenur Gürbüz, Ibrahim Bozgeyik, Demet Taşdemir, Hamada Hashem, Stefan Bräse, Claudiu T Supuran iD

ChemMedChem · 14.07.2026 · 21 (13)

DOI: 10.1002/cmdc.70369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 06.07.2026. Verfasst von Suleyman Akocak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Adıyaman University, Adıyaman, Türkiye. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Sulfonamides, Pyrazoles, Carbonic Anhydrases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel library of diazo and pyrazole‐carboxamide‐linked molecules containing the sulfonamide pharmacophore was developed and synthesized, yielding selective inhibitors of clinically relevant carbonic anhydrase (CA) isoforms. The synthesis method involved the production of diazonium salts from 4‐ and 3‐aminobenzenesulfonamide precursors, followed by cyclization and further functionalization to yield structurally diverse pyrazole derivatives. All compounds were evaluated for their inhibitory efficacy against hCA I and II (cytosolic isoforms) and the tumor‐associated isoenzymes hCA IX and XII; also, cytotoxicity and molecular modeling studies were conducted for the compounds. The newly synthesized hybrid compounds displayed extensive inhibitory activity, with most derivatives showing significant potency and selectivity for cancer‐associated isoforms. More specifically, para‐substituted analogs exhibited enhanced inhibitory properties relative to their meta‐substituted counterparts. Compound 5f , with a 3,4‐dichloro motif, exhibited the highest activity with a very low K I value of 1.8 nM against hCA IX, greatly surpassing the reference drug acetazolamide. Electron‐withdrawing substituents improved inhibitory efficacy, whereas electron‐donating groups often reduced activity. Furthermore, compounds 5f (A549: 41.17 μM; HCT116: 4.47 μM) and 6c (A549: 14.64 μM; HCT116: 4.03 μM) showed the lowest IC 50 values in both cell lines. The findings emphasize diazo‐ and pyrazole‐carboxamide‐linked benzenesulfonamides as promising scaffolds for advancing isoform‐selective carbonic anhydrase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsSulfonamidesPyrazolesCarbonic AnhydrasesHumansBenzenesulfonamidesStructure-Activity RelationshipCarbonic Anhydrase IIIsoenzymesAntigens, NeoplasmCarbonic Anhydrase IMolecular StructureCell Line, TumorCarbonic Anhydrase IXDose-Response Relationship, Drug

Stichwörter der Autor:innen

cancercarbonic anhydrasediazoisoformpyrazole‐carboxamide

Substanzen

Carbonic Anhydrase InhibitorsSulfonamidesPyrazolesCarbonic AnhydrasesBenzenesulfonamidesCarbonic Anhydrase IIIsoenzymesAntigens, NeoplasmpyrazoleCarbonic Anhydrase I

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Adıyaman University, Adıyaman, Türkiye.
  • Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Florence, Italy.
  • Faculty of Pharmacy, Adıyaman University, Adıyaman, Türkiye.
  • Department of Medical Biology, Faculty of Medicine, Adıyaman University, Adıyaman, Türkiye.
  • Department of Medical Biochemistry, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt.

ORCID-Profile: Suleyman Akocak, Nebih Lolak, Claudiu T Supuran

Förderung

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Zitieren

APA

Akocak, S., Lolak, N., Ammara, A., Gürbüz, G., Bozgeyik, I., Taşdemir, D., Hashem, H., Bräse, S., & Supuran, C. T. (2026). Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII. ChemMedChem, 21(13). https://doi.org/10.1002/cmdc.70369

Vancouver

Akocak S, Lolak N, Ammara A, Gürbüz G, Bozgeyik I, Taşdemir D, et al. Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII. ChemMedChem. 2026;21(13). doi:10.1002/cmdc.70369

BibTeX
@article{Akocak2026,
  author = {Akocak, Suleyman and Lolak, Nebih and Ammara, Andrea and Gürbüz, Gökçenur and Bozgeyik, Ibrahim and Taşdemir, Demet and Hashem, Hamada and Bräse, Stefan and Supuran, Claudiu T},
  title = {Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {13},
  doi = {10.1002/cmdc.70369}
}
Kostenlos starten →